+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Comparison of two pre-exposure treatment regimens in acute organophosphate (paraoxon) poisoning in rats: tiapride vs. pyridostigmine



Comparison of two pre-exposure treatment regimens in acute organophosphate (paraoxon) poisoning in rats: tiapride vs. pyridostigmine



Toxicology and Applied Pharmacology 219(2-3): 235-240



Recently, the FDA approved the medical use of oral pyridostigmine as prophylactic treatment of possible nerve agent exposure: the concept is to block the cholinesterase transitorily using the carbamate (pyridostigmine) in order to deny access to the active site of the enzyme to the irreversible inhibitor (nerve agent) on subsequent exposure. We have shown previously that tiapride is in vitro a weak inhibitor of acetylcholinesterase and that in rats administration of tiapride before the organophosphate paraoxon significantly decreases mortality. The purpose of the present study was to compare tiapride- and pyridostigmine-based pretreatment strategies, either alone or in combination with pralidoxime reactivation, by using a prospective, non-blinded study in a rat model of acute high-dose paraoxon exposure. Groups 1-6 received 1 microMol paraoxon (approximately LD75) groups 2-6 received in addition: G(2)50 microMol tiapride 30 min before paraoxonG(3)50 microMol tiapride 30 min before paraoxon and 50 microMol pralidoxime 1 min after paraoxon G41 microMol pyridostigmine 30 min before paraoxon G(5)1 microMol pyridostigmine 30 min before paraoxon and 50 microMol pralidoxime 1 min after paraoxon G(6)50 microMol pralidoxime 1 min after paraoxon. Mortality data were compared using Kaplan-Meier plots and logrank tests. Mortality is statistically significantly influenced by all treatment strategies. Tiapride pretreatment followed by pralidoxime treatment (G3) is aux par with pyridostigmine pretreatment followed by pralidoxime treatment (G5). Tiapride pretreatment only (G2) is inferior to pyridostigmine pretreatment only (G4). The best results are achieved with pyridostigmine pretreatment only or pralidoxime treatment only (G4 and G6).

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 013235036

Download citation: RISBibTeXText

PMID: 17056080

DOI: 10.1016/j.taap.2006.09.002


Related references

Tiapride pre-treatment in acute exposure to paraoxon: comparison of effects of administration at different points-in-time in rats. Molecular and Cellular Biochemistry 285(1-2): 79-86, 2006

Ranitidine in acute high-dose organophosphate exposure in rats: effect of the time-point of administration and comparison with pyridostigmine. Basic & Clinical Pharmacology & Toxicology 99(4): 312-316, 2006

Combined forced running stress and subclinical paraoxon exposure have little effect on pyridostigmine-induced acute toxicity in rats. Toxicology 190(3): 221-230, August 28th, 2003

Effect of pyridostigmine, pralidoxime and their combination on survival and cholinesterase activity in rats exposed to the organophosphate paraoxon. Archives of Toxicology 80(11): 777-784, 2006

Protective drugs in acute large-dose exposure to organophosphates: a comparison of metoclopramide and tiapride with pralidoxime in rats. Anesthesia and Analgesia 100(2): 382-386, 2005

Usefulness of administration of non-organophosphate cholinesterase inhibitors before acute exposure to organophosphates: assessment using paraoxon. Journal of Applied Toxicology 33(9): 894-900, 2013

Efficacy comparison of two cholinolytics scopolamine and azaprophen when used in conjunction with physostigmine and pyridostigmine for protection against organophosphate exposure. Journal of the American College of Toxicology 10(2): 215-222, 1991

Comparison of current recommended regimens of atropinization in organophosphate poisoning. Journal of Medical Toxicology 10(2): 143-147, 2014

Five oximes (K-27, K-33, K-48, BI-6 and methoxime) in comparison with pralidoxime: survival in rats exposed to the organophosphate paraoxon. Journal of Applied Toxicology 26(3): 262-268, 2006

New K-Oximes (K-27 and K-48) in Comparison with Obidoxime (LuH-6), HI-6, Trimedoxime (TMB-4), and Pralidoxime (2-PAM): Survival in Rats Exposed IP to the Organophosphate Paraoxon. Toxicology Mechanisms and Methods 17(7): 401-408, 2007

Acute effects of the organophosphate paraoxon on schedule-controlled behavior and esterase activity in rats: dose-response relationships. Pharmacology Biochemistry and Behavior 40(4): 929-936, 1991

Protective agents in acute high-dose organophosphate exposure: comparison of ranitidine with pralidoxime in rats. Journal of Applied Toxicology 25(1): 68-73, 2005

Paraoxon sensitive phenylvalerate hydrolase in assessing the severity of acute paraoxon poisoning. Journal of Toxicology. Clinical Toxicology 39(1): 27-31, 2001

Oxidative stress resulting from exposure of a human salivary gland cells to paraoxon: an in vitro model for organophosphate oral exposure. Toxicology in Vitro 28(5): 715-721, 2014